Dr Reddys Laboratories RDY
NYSE RDY
$11.85 -0.03 (-0.29%)
As of: Sep 9, 2026 · 3:04 PM EDT

Dr Reddys Laboratories (RDY) Operating Margin (2009 - 2026)

Dr Reddys Laboratories (RDY) posted Operating Margin of 4.69% for Q2 2026, up 165.97% on a QoQ basis from 1.76% in Q1 2026, and down 1576.0% year-over-year from 0.32% in Q2 2025.

Analysis

Dr Reddys Laboratories (RDY) Operating Margin (2009 - 2026) Analysis & Trends

Dr Reddys Laboratories has reported Operating Margin for 18 years, with the latest figure at 4.69% in Q2 2026.

  • On a quarterly basis, Operating Margin fell 1576.0% year-over-year to 4.69% in Q2 2026; TTM through Jun 2026 was 11.33%, a 1004.0% decrease from a year earlier, with the FY2026 full-year figure at 15.06%, down 681.0% from the prior year.
  • Operating Margin was 4.69% for Q2 2026 at Dr Reddys Laboratories, up from 1.76% in the prior quarter.
  • The five-year high for Operating Margin was 26.14% in Q1 2023, with the low at 1.76% in Q1 2026.
  • Average Operating Margin over 5 years is 19.16%, with a median of 21.51% recorded in 2024.
  • The sharpest annual moves came in 2023 and 2026: Operating Margin jumped 2335 bps in 2023, then sank 1898 bps in 2026.
  • Over 5 years, Operating Margin stood at 19.69% in 2022, then rose by 22 bps to 23.93% in 2023, then slipped by 6 bps to 22.4% in 2024, then dropped by 27 bps to 16.32% in 2025, then plunged by 71 bps to 4.69% in 2026.
  • The last three Operating Margin figures came in at 4.69% (Q2 2026), 1.76% (Q1 2026), and 16.32% (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Teva Pharmaceutical Industries 42.53 Bn 38.88 Bn 2.15 Bn -5.58%
2 Viatris 19.14 Bn 18.25 Bn 1.46 Bn 0.17%
3 Dr Reddys Laboratories 9.86 Bn 9.69 Bn 396.53 Mn 4.69%
4 Amneal Pharmaceuticals 5.45 Bn 5.33 Bn 334.51 Mn 16.30%
5 Bausch Health Companies 2.33 Bn 492.63 Mn 2.10 Bn 25.95%
6 Alvotech 1.51 Bn 1.36 Bn 2.56 Mn -134.08%
7 Ani Pharmaceuticals 1.48 Bn 1.12 Bn 165.89 Mn 15.21%
8 Amphastar Pharmaceuticals 992.90 Mn 702.78 Mn 93.47 Mn 21.60%
9 Fennec Pharmaceuticals 400.20 Mn 358.95 Mn 17.15 Mn 9.72%
10 RedHill Biopharma 178.79 Mn 178.79 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.69%
Mar 31, 2026 1.76%
Dec 31, 2025 16.32%
Sep 30, 2025 19.89%
Jun 30, 2025 20.45%
Mar 31, 2025 20.75%
Dec 31, 2024 22.40%
Sep 30, 2024 21.89%
Jun 30, 2024 23.36%
Mar 31, 2024 21.12%
Dec 31, 2023 23.93%
Sep 30, 2023 25.97%
Jun 30, 2023 25.97%
Mar 31, 2023 26.14%
Dec 31, 2022 19.69%
Sep 30, 2022 24.27%
Jun 30, 2022 23.42%
Mar 31, 2022 2.79%
Dec 31, 2021 10.46%
Sep 30, 2021 17.40%